These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15902668)

  • 1. Afibrinogenemia and a circulating antibody against fibrinogen in a Bichon Frise dog.
    Wilkerson MJ; Johnson GS; Stockham S; Riley L
    Vet Clin Pathol; 2005 Jun; 34(2):148-55. PubMed ID: 15902668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of afibrinogenemia in a chihuahua.
    Chambers G
    J Am Anim Hosp Assoc; 2013; 49(1):70-4. PubMed ID: 23148136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinogen deficiency in a dog - a case report.
    Jolivet F; Diquélou A; Trumel C; Privat S; Dossin O
    BMC Vet Res; 2017 Jun; 13(1):183. PubMed ID: 28629414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An
    Mischke R; Metzger J; Distl O
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of storage conditions on hemostatic parameters of canine plasma obtained for transfusion.
    Iazbik C; Couto CG; Gray TL; Kociba G
    Am J Vet Res; 2001 May; 62(5):734-5. PubMed ID: 11341394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen Houston: a dysfibrinogen exhibiting defective fibrin monomer aggregation and alpha-chain cross-linkages.
    Weinger RS; Rudy C; Moake JL; Conlon CL; Cimo PL
    Am J Hematol; 1980; 9(3):237-48. PubMed ID: 6165239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the prothrombin time-derived and Clauss assays for the measurement of plasma fibrinogen in hospitalized dogs.
    Hasiuk MH; Russell KE; Jeffery U
    Vet Clin Pathol; 2020 Sep; 49(3):394-400. PubMed ID: 32654209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired Dysfibrinogenemia Caused by Autoantibody Inhibiting Fibrin Polymerization in a Patient with MELAS Syndrome and Bleeding Tendency.
    Lee N; Kim JE; Yoo HJ; Gu J; Kim H; Chung J; Koh Y; Kim HK
    Ann Clin Lab Sci; 2016 Dec; 46(6):696-700. PubMed ID: 27993886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboelastographic profile for a dog with hypocoagulable and hyperfibrinolytic phase of disseminated intravascular coagulopathy.
    Vilar-Saavedra P; Hosoya K
    J Small Anim Pract; 2011 Dec; 52(12):656-9. PubMed ID: 22136449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients.
    Drews RE
    Clin Chest Med; 2003 Dec; 24(4):607-22. PubMed ID: 14710693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombokinetic studies in normal and factor VIII-deficient canine plasmas.
    Johnstone IB
    Can J Comp Med; 1983 Apr; 47(2):157-62. PubMed ID: 6603892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive roles of platelets and fibrinogen in whole-blood fibrin clot formation upon dilution as assessed by thromboelastometry.
    Ninivaggi M; Feijge MA; Baaten CC; Kuiper GJ; Marcus MA; Ten Cate H; Lancé MD; Heemskerk JW; van der Meijden PE
    Thromb Haemost; 2014 Mar; 111(3):447-57. PubMed ID: 24258426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfibrinogenemia and lupus anticoagulant in a patient with recurrent thrombosis.
    Al-Mondhiry H; Galanakis D
    J Lab Clin Med; 1987 Dec; 110(6):726-33. PubMed ID: 3119749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Congenital afibrinogenemia caused by a novel insertion mutation in the FGB gene].
    Zhang J; Zhao XJ; Wang ZY; Yu ZQ; Cao LJ; Ma ZN; Zhang J; Zhang W; Bai X; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):751-6. PubMed ID: 24103871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen Oviedo I. A new Spanish dysfibrinogenaemia.
    Fernández FJ; Rodríguez Pinto C; Páramo J; Cuesta B; Collado M; Rocha E
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):571-5. PubMed ID: 2133236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired dysfibrinogenemia secondary to mithramycin toxicity.
    Ashby MA; Lazarchick J
    Am J Med Sci; 1986 Jul; 292(1):53-5. PubMed ID: 2940861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of thrombin generation in plasma by fibrin formation (Antithrombin I).
    de Bosch NB; Mosesson MW; Ruiz-Sáez A; Echenagucia M; Rodriguez-Lemoin A
    Thromb Haemost; 2002 Aug; 88(2):253-8. PubMed ID: 12195697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of disseminated intravascular coagulation in dogs admitted to an intensive care unit.
    Bateman SW; Mathews KA; Abrams-Ogg AC; Lumsden JH; Johnstone IB; Hillers TK; Foster RA
    J Am Vet Med Assoc; 1999 Sep; 215(6):798-804. PubMed ID: 10496131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen.
    Stang LJ; Mitchell LG
    Methods Mol Biol; 2013; 992():181-92. PubMed ID: 23546714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysfibrinogenaemia characterized by abnormal fibrin monomer polymerization and normal fibrinopeptide A release.
    Lane DA; Cuddigan B; VanRoss M; Kakkar VV
    Br J Haematol; 1980 Mar; 44(3):483-94. PubMed ID: 6769460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.